Key Insights

Highlights

Treatment Research

1 treatments under study, led by Press Guide

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1
Active Not Recruiting1

Clinical Trials (2)

Research Network

Common Treatments

  • Press Guide1

Active Sponsors

  • Rambam Health Care Campus1
  • White River Junction Veterans Affairs Medical Center1
  • Technion, Israel Institute of Technology1
  • National Cancer Institute (NCI)1

Top Investigators

Related Conditions

  • Clinical Decisionmaking1
  • Emergency Department Visit1
  • Information Systems1
  • Artificial Intelligence In Medicine1
  • Electronic Health Records1

Activity Timeline